Abstract
Lung cancer is currently the cancer with the highest incidence and mortality in the world.Non-small cell lung cancer accounts for more than 85% of lung cancer.With a deep study of tumor biology, multiple mutations as therapeutic targets have been identified in recent ten years, wherein the frequency of epidermal growth factor receptor (EGFR) mutation is the highest.Therefore, EGFR targeted therapy of non-small cell lung cancer has become the main force.This review presents EGFR mutation and targeted therapies of non-small cell lung cancer. Key words: Non-small cell lung cancer; Epidermal growth factor receptor; Targeted therapy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
